Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Boundless Bio
Research
Drug shrinks tumors in mice by targeting extrachromosomal DNA
The compound from Boundless Bio shrank gastric tumors and prevented the cancer from developing resistance to another cancer drug.
Darren Incorvaia
Nov 6, 2024 12:50pm
Boundless Bio makes 'modest' layoffs 5 months after $100M IPO
Aug 13, 2024 4:27am
Boundless boldly goes public with $100M IPO
Mar 28, 2024 7:10am
Boundless Bio eyes $88M offering as spring IPO market blooms
Mar 21, 2024 8:50am
Boundless Bio bumps IPO market back to life
Mar 6, 2024 5:20pm
FDA's Peter Marks doesn't plan to retire soon—Chutes & Ladders
Aug 4, 2023 9:30am